Tobin C Schilke

Title: Tobin C Schilke: Innovator in Pharmaceutical Chemistry

Introduction

Tobin C Schilke is a notable inventor based in St. Louis, MO (US). He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds and processes. With a total of 2 patents to his name, Schilke's work has implications for the treatment of various medical conditions.

Latest Patents

One of Schilke's latest patents is titled "Process for making substituted pyrazoles." This invention focuses on a method for synthesizing substituted pyrazoles, their tautomers, and salts. The substituted pyrazoles correspond in structure to a specific formula defined in the patent specification. Another significant patent is for "Solid-state forms of N-(2-hydroxyacetyl)-5-(4-piperidyl)-4-(4-pyrimidinyl)-3-(4-chlorophenyl) pyrazole." This patent provides crystalline forms of a p38 kinase inhibitor, detailing various anhydrous and solvated forms that possess unique properties and improved stability. These forms are essential for the preparation of pharmaceutical compositions aimed at treating p38 kinase-mediated conditions.

Career Highlights

Tobin C Schilke is associated with Pharmacia Corporation, where he has contributed to innovative research and development in pharmaceutical sciences. His work has been instrumental in advancing the understanding and application of pyrazole compounds in therapeutic settings.

Collaborations

Throughout his career, Schilke has collaborated with notable colleagues, including Kimberley C Allen and Jerry D Clark. These collaborations have fostered a productive environment for innovation and discovery in the pharmaceutical industry.

Conclusion

Tobin C Schilke's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as an influential inventor. His work continues to impact the development of new therapeutic agents.